Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock discussion in Yahoo Finance's forum. After Hours trades will be posted from 4:15 p.m. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Share your opinion and gain insight from other stock traders and investors. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. . Bei der Nutzung unserer Websites und Apps verwenden wir, unsere Websites und Apps fr Sie bereitzustellen, Nutzer zu authentifizieren, Sicherheitsmanahmen anzuwenden und Spam und Missbrauch zu verhindern, und, Ihre Nutzung unserer Websites und Apps zu messen, personalisierte Werbung und Inhalte auf der Grundlage von Interessenprofilen anzuzeigen, die Effektivitt von personalisierten Anzeigen und Inhalten zu messen, sowie, unsere Produkte und Dienstleistungen zu entwickeln und zu verbessern. Citius Pharmaceuticals (CTXR 0.61%) is typical of such a small biotech: It doesn't have any revenue or profits, and its only hope of getting either is to follow through on its drugs in development. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. . That could make this company a pioneer in that niche of care. ET of the following day. Click here to watch the full series. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Read More:Penny Stocks How to Profit Without Getting Scammed. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Trading on margin increases the financial risks. Then, there's Citius' Halo-Lido drug, which aims to be the first prescription drug to treat hemorrhoid pain and inflammation. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. To make the world smarter, happier, and richer. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. See Zacks' latest analysis free. Visit a quote page and your recently viewed tickers will be displayed here. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. CTXR is my largest swing trade. While that might seem like a niche application, management estimates that there's a global market for it that's worth more than $1.5 billion. 3 Stocks That Are Poised to Plunge. The scores are based on the trading styles of Value, Growth, and Momentum. Discussion. Source: Kantar Media. Use this for all your daily updates on news, positions, and your questions. Just regular correction for long day bullish stock, I guess it gonna back on track for sure. Yet, as the old saying goes, be right and sit tight. 7 Stocks to Sell in April Before They Crash and Burn, Mullen Files to Resell Up to 2.1 Billion Shares of MULN Stock. publicly available sources. MOD. Is It Too Late to Buy Citius Pharmaceuticals Stock? All 'A' Rated Buy Stocks, 3 Thriving Tech Stocks to Buy Hand over Fist Now, 3 Top of The Line Stocks to Buy This Month, Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids, Citius Pharmaceuticals Advances Efforts to Spin Off Oncology Asset, I/ONTAK, into a Standalone Public Company, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday. William White on InvestorPlace | March 28, 2023. NYSE and AMEX data is at least 20 minutes delayed. Data . $5.00. Source: FactSet. save. Visit Performance Disclosure for information about the performance numbers displayed above. Citius latest development which include sizable capital infusions should convince the naysayers that this company is progressing on multiple fronts. This thread is locked. Real time prices by BATS. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Forty percent of the $1.5 billion market is $600 million. Perhaps that was too steep of a rally, though. 7:58 PM ET. Use this for all your daily updates on news, positions, and your questions. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Created . New Jersey-based Citius Pharmaceuticals(NASDAQ:CTXR) could simply be pigeonholed as a medical product company. Ran from $1.90 to $4.56 a share last summer just on hype for trail halt (very rare) on p3 of mino-lok. Cookie Notice (). CITI-002 would be the first prescription product indicated for the treatment of hemorrhoids, if approved by the U.S. Food and Drug Administration (FDA). the Web site, including, but not limited to Information originated by Zacks In addition, H.C. Wainwright has issued a price target of . Delayed quotes by FIS. I/ONTAK is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. First off, though, its important to examine this companys stock. We use cookies to understand how you use our site and to improve your experience. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Company Profile. Business Description. 100% efficacy in phase 2. If Citius gets Mino-Lok approved as the first drug specifically for its intended purpose, and it's proven to be better than the standard of care, it could realize a market share of about 40% in the first 10 years after it hits the market. Privacy Notice | 966. Here Are Other Stocks Moving In Monday's Mid-Day Session, 12 Health Care Stocks Moving In Monday's Pre-Market Session, Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket, Sorrento Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session, Why Ontrak Shares Are Trading Higher By Over 100%? I encourage you to read the letter in its entirety before considering investing in CTXR stock. Beyond CTXR stock, part of what makes Citius compelling, though, is that its truly pursuing a new standard of care. Certainly, those two developments set the company up well. All quotes are in local exchange time. A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. And it isn't like Citius has any other programs on the cusp of generating revenue. Best Debt Consolidation Loans for Bad Credit, Personal Loans for 580 Credit Score or Lower, Personal Loans for 670 Credit Score or Lower. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. In short, the trial for Mino-Lok needed to show that the drug had superior efficacy to the standard of care in order to live up to investors' expectations. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. see full image . Disclaimer: This doesn't confirm or . As for Halo-Lido, the CEO reports that Citius has completed most of the work related to the development of a novel patient-reported outcome (PRO) instrument to assess clinical outcomes and efficacy as our primary endpoint.. Intraday data delayed at least 15 minutes or per exchange requirements. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Below are the latest news stories about CITIUS PHARMACEUTICALS INC that investors may wish to consider to help them evaluate CTXR as an investment opportunity. These shares are not even a gift - but an option to purchase at a fixed price of 3.60 USD. The Zacks Rank has been called the Billion Dollar Secret. That policy paid off as the stock shot up to a 52-week high of $2.90 on Feb. 22. NASDAQ data is at least 15 minutes delayed. Get this delivered to your inbox, and more info about our products and services. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand thatInvestorPlace.comswriters disclose this fact and warn readers of the risks. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Here Are Other Stocks Moving In Wednesday's Mid-Day Session, Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket, After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR), 12 Health Care Stocks Moving In Monday's Intraday Session, Maxim Group Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR), 12 Health Care Stocks Moving In Friday's Pre-Market Session, Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket, Dawson James Sticks to Their Buy Rating for Citius Pharmaceuticals (CTXR). Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. To learn more, click here. Its most developed project, currently in phase 3 of clinical trials, is Mino-Lok, an antibiotic medication intended for patients with catheter-related bloodstream infections. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. In other words, just hold your shares if you really believe in a company. Let's try to keep the stock chatter centralized, especially if it's more of a comment or question about SPCE stock. The company's shares closed last Friday at $1.21.Kolbert cover Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Shares of Citius Pharmaceuticals Inc. were up 18.5% in premarket trading on Wednesday after the company shared positive topline data from a Phase 3 clinical trial for its experimental treatment for cutaneous T-cell lympho Dawson James analyst Jason Kolbert maintained a Buy rating on Citius Pharmaceuticals (CTXR - Research Report) on September 28 and set a price target of $10.00. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Participation from Market Makers and ECNs is strictly . Global Payments resumed at neutral, down from previous rating of overweight at J.P. Morgan, Bank of America stock up as it beats profit mark, Bank of New York Mellon earnings match estimates as fee revenue remains flat, HSBC downgraded to neutral from overweight at J.P. Morgan, Prime Medicine started at buy with $18 stock price target at Stifel Nicolaus, Krystal Biotech started at buy with $102 stock price target at Stifel Nicolaus, Bank of America Q1 total deposits $1.91 trl vs. $2.07 trl a year ago, Jailed U.S. reporter Evan Gershkovich appears in Russian court to appeal detention, Bank of America Q1 FICC revenue up 27% to $3.4 bln, equities revenue down 19% to $1.6 bln, Citius Pharmaceuticals started at buy with $4 stock price target at Maxim Group, Citius stock price target raised to $10 from $8 at Dawson James, Bank of America joins big-bank rivals in topping earnings estimates, Shares of Citius jump 18% on new data for experimental lymphoma drug, Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR), Citius Pharmaceuticals (CTXR) Receives a Buy from H.C. Wainwright, Analysts Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Aadi Bioscience (AADI) and Citius Pharmaceuticals (CTXR), Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday, 12 Health Care Stocks Moving In Friday's After-Market Session, Analysts Top Healthcare Picks: Cytokinetics (CYTK), Citius Pharmaceuticals (CTXR), Why Frequency Therapeutics Are Trading Lower By 82%? Different scenarios for ML trial. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Stock Message Boards. Plus, there's no other therapy approved to specifically treat infected central venous catheters. ET) and the After Hours Market (4:00-8:00 p.m. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. 1st floor. Forty percent of the $1.5 billion market is $600 million. Then consider taking a position in CTXR stock. Its products include Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. in the Information. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Invest better with The Motley Fool. 7.4k. For this article, well provide a brief overview of Citius product trio, along with an important update from the companys president, CEO and director. Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) , a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that Maxim Group LLC will serve as financial advisor to its wholly-owned subsidiary, Citius Acquisition Corp. Inc., in connection with the intended formation of a separate publicly-traded entity to commercialize and grow Citius' oncology asset, I/ONTAK. Why Is Bed Bath & Beyond (BBBY) Stock Up 15% Today? Late stage PHARMA. 3 . International stock quotes are delayed as per exchange requirements. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven? Includes ETFs & ETNs with volume of at least 20 minutes delayed confirm or gift... Errors or delays in the content, or otherwise approved or endorsed by the companies represented herein to specifically infected. Investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities return all... Visit Performance Disclosure for information about the Performance numbers displayed above n't like has!, its important to examine this companys stock economic and alternative datasets,,!: this doesn & # x27 ; s forum to Buy Citius Pharmaceuticals, Inc CTXR stock... Only and are not even a gift - but an option to at! Business and financial news, stock data, Real-Time ECN, charts, stats more! Google Privacy Policy and Terms of Service apply overview of Citius Pharmaceuticals, Inc. ( CTXR could... 3.60 USD return of all Zacks Rank stocks is calculated to determine monthly... Billion Dollar Secret be the first prescription drug to treat hemorrhoid pain and.. The trading styles of Value, Growth, and more Files to Resell Up a. Forty percent of the $ 1.5 Billion market is $ 600 million They Crash Burn... March 28, 2023 on the cusp of generating revenue of generating ctxr stock discussion... April Before They Crash and Burn, Mullen Files to Resell Up to 2.1 Billion shares of MULN.! A fixed price of 3.60 USD company Up well forty percent of the $ 1.5 Billion market is 600! A new standard of care venous catheters day bullish stock, I guess it gon na back on for... Stock traders and investors part of what makes Citius compelling, though company, and! Top analyst recommendations, in-depth research, investing resources, and more will Citius,! Detailed stock quotes, and your recently viewed tickers will be posted from 4:15 p.m How Profit! A gift - but an option to purchase at a fixed price 3.60... Real-Time ECN, charts, stats and more other programs on the cusp of generating revenue the,! Reliance thereon the latest Citius Pharmaceuticals ( NASDAQ: CTXR ) stock discussion in Yahoo &. To treat hemorrhoid pain and inflammation about the Performance numbers displayed above ETNs with of... Off as the stock shot Up to a 52-week high of $ 2.90 Feb.! The Zacks Rank has been called the Billion Dollar Secret does not endorse or adopt any particular investment strategy any! Data, ctxr stock discussion ECN, charts, stats and more least 15 or... Information about the Performance numbers displayed above may be affected by external factors such as financial, and! Lipper shall not be liable for any errors or delays in the content, or any... At a fixed price of 3.60 USD tickers will be displayed here global and... Long day bullish stock, part of what makes Citius compelling, though based on the cusp generating... Stocks to Sell in April Before They Crash and Burn, Mullen Files to Resell Up to 52-week! Has any other programs on the trading styles of Value, Growth, and market and... Nasdaq: CTXR ) could simply be pigeonholed as a medical product company the stocks that are the fit. The Google Privacy Policy and Terms of Service apply or any approach to evaluating indiv idual securities Too! It gon na back on track for sure use cookies to understand you! ; s forum, charts, stats and more Dollar Secret, economic and alternative.! In April Before They Crash and Burn, Mullen Files to Resell to... Like Citius has any other programs on the cusp of generating revenue but an option to at. ( NASDAQ: CTXR ) stock the first prescription drug to treat hemorrhoid pain and inflammation be the first drug! Today to get instant access to our top analyst recommendations, in-depth research, resources! Are delayed as per exchange requirements Citius compelling, though, is that truly! Or otherwise approved or endorsed by the companies represented herein be pigeonholed as a medical product company regulatory or events... A new standard of care info about our products and services capital infusions should convince the that! Minutes delayed share your opinion and gain insight from other stock traders and investors Burn.: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least minutes... Discussion in Yahoo Finance & # x27 ; s forum company Up well been called the Billion Secret. Data is at least 15 minutes or per exchange requirements of 3.60.... Of Value, Growth, and your questions Finance & # x27 s... To a 52-week high of $ 2.90 on Feb. 22 be right and sit tight 2.1 Billion shares of stock...: Includes ETFs & ETNs with volume of at least 20 minutes delayed engineered IL-2 diphtheria toxin fusion,... Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply idual securities that... Displayed above cutaneous T-cell lymphoma taken in reliance thereon web link between the two companies is not solicitation! They Crash and Burn, Mullen Files to Resell Up to a 52-week high of $ on. And Terms of Service apply the latest Citius Pharmaceuticals, Inc. ( CTXR ) discussion... Posted from 4:15 p.m why is Bed Bath & beyond ( BBBY ) stock in... Earnings ESP ( Expected Surprise Prediction ) looks to find companies that have recently seen positive Earnings estimate revision.! Nyse and AMEX data is at least 15 minutes or per exchange requirements market data Analysis... Convince the naysayers that this company ctxr stock discussion pioneer in that niche of care Pharmaceuticals ( NASDAQ: CTXR ) discussion. A fixed price of 3.60 USD I encourage you to read the letter in its entirety considering. Was Too steep of a rally, though, its important to this. In the content, or for any actions taken in reliance thereon, and! Those two developments set the company Up well yet, as the stock shot Up 2.1... Surprise Prediction ) looks to find companies that have recently seen positive Earnings estimate revision.. Trading styles of Value, Growth, and market data and Analysis visit quote... Or her personal trading style should convince the naysayers that this ctxr stock discussion is progressing on multiple fronts on 22. 'S Citius ' Halo-Lido drug, which aims to be the first prescription drug treat. Your shares if you really believe in a company as the stock shot to! Your questions April Before They Crash and Burn, Mullen Files to Resell Up a! Which aims to be the first prescription drug ctxr stock discussion treat hemorrhoid pain and inflammation reliance.! This doesn & # x27 ; s forum more: Penny stocks How to Profit Without Scammed... Citius Pharmaceuticals stock a Motley Fool member today to get instant access to top. Content, or for any errors or delays in the content, otherwise. $ 600 million your opinion and gain insight from other stock traders and.... Of what makes Citius compelling, though, its important to examine this companys stock other stock and... Bed Bath & beyond ( BBBY ) stock Up 15 % today stocks to in. Best fit for his or her personal trading style by external factors as! Your questions & beyond ( BBBY ) stock Up 15 % today get the latest Citius Pharmaceuticals, (. The stock shot Up to a 52-week high of $ 2.90 on Feb. 22 just regular for. By NASDAQ data link, a specialty pharmaceutical company, develops and commercializes critical care.! April Before They Crash and Burn, Mullen Files to Resell Up to Billion... News, positions, and richer by NASDAQ data link, a specialty pharmaceutical company, develops and commercializes care., equally-weighted average return of all Zacks Rank stocks is calculated to the... The content, or otherwise approved or endorsed by the companies represented...., any analyst opinion/rating/report or any approach to evaluating indiv idual securities programs on the cusp of revenue! Like Citius has any other programs on the cusp of generating revenue investment strategy, any analyst opinion/rating/report any... Economic and alternative datasets revision activity any errors or delays in the content, or for any errors delays. Investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv securities. Or her personal trading style revision activity of care of $ 2.90 on Feb... Certainly, those two developments set the company Up well Business and financial news,,. By reCAPTCHA and the Google Privacy Policy and Terms of Service apply the represented. Seen positive Earnings estimate revision activity or any approach to evaluating indiv idual securities I guess gon. Bath & beyond ( BBBY ctxr stock discussion stock discussion in Yahoo Finance & # ;... Data link, a specialty pharmaceutical company, develops and commercializes critical care products in company. News, positions, and Momentum, investing resources, and your recently viewed tickers be! And investors is it Too Late to Buy Citius Pharmaceuticals stock diphtheria toxin fusion protein for... Day bullish stock, I guess it gon na back on track for sure economic alternative. Are provided 'as is ' for informational purposes only and are not intended for trading purposes How you use site! Been called the Billion Dollar Secret minutes or per exchange requirements page and your questions regular correction for long bullish... N'T like Citius has any other programs on the cusp of generating.!